Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma

被引：5

作者：

Clements, Hollie A. ^{[1
,2
]}

Underwood, Tim J. ^{[3
]}

Petty, Russell D. ^{[1
,2
,4
,5
]}

机构：

[1] Univ Dundee, Ninewells Hosp, Div Mol & Clin Med, Dundee, Scotland

[2] Univ Dundee, Med Sch, Dundee, Scotland

[3] Univ Southampton, Univ Hosp Southampton NHS Fdn Trust, Sch Canc Sci, Southampton, England

[4] NHS Tayside, Ninewells Hosp, Tayside Canc Ctr, Dundee, Scotland

[5] NHS Tayside, Med Sch, Dundee, Scotland

来源：

BRITISH JOURNAL OF CANCER | 2024年 / 130卷 / 01期

关键词：

ADVANCED RECTAL-CANCER; PEMBROLIZUMAB PLUS CHEMOTHERAPY; LOCALLY ADVANCED ESOPHAGEAL; PHASE-III TRIAL; PREOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; OPEN-LABEL; GASTRIC-CANCER; PERIOPERATIVE CHEMOTHERAPY; IMPROVED SURVIVAL;

D O I：

10.1038/s41416-023-02458-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Adenocarcinoma of the oesophagus and gastro-oesophageal junction represent a large burden of cancer death in the Western World with an increasing incidence. In the past two decades, the overall survival of patients on a potentially curative treatment pathway has more than doubled due to the addition of perioperative oncological therapies to surgery. However, patients often fail to respond to oncological treatment or struggle to complete their treatment after surgery. In this review, we discuss the current evidence for total neoadjuvant therapy and options for assessment of treatment response.

引用

页码：9 / 18

页数：10

共 110 条

[1]

Al-Batran SE, 2022, J CLIN ONCOL, V40

[2] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Homann, Nils ;

Pauligk, Claudia ;

Goetze, Thorsten O. ;

Meiler, Johannes ;

Kasper, Stefan ;

Kopp, Hans-Georg ;

Mayer, Frank ;

Haag, Georg Martin ;

Luley, Kim ;

Lindig, Udo ;

Schmiegel, Wolff ;

Pohl, Michael ;

Stoehlmacher, Jan ;

Folprecht, Gunnar ;

Probst, Stephan ;

Prasnikar, Nicole ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Trojan, Joerg ;

Koenigsmann, Michael ;

Martens, Uwe M. ;

Thuss-Patience, Peter ;

Egger, Matthias ;

Block, Andreas ;

Heinemann, Volker ;

Illerhaus, Gerald ;

Moehler, Markus ;

Schenk, Michael ;

Kullmann, Frank ;

Behringer, Dirk M. ;

Heike, Michael ;

Pink, Daniel ;

Teschendorf, Christian ;

Loehr, Carmen ;

Bernhard, Helga ;

Schuch, Gunter ;

Rethwisch, Volker ;

von Weikersthal, Ludwig Fischer ;

Hartmann, Joerg T. ;

Kneba, Michael ;

Daum, Severin ;

Schulmann, Karsten ;

Weniger, Joerg ;

Belle, Sebastian ;

Gaiser, Timo ;

Oduncu, Fuat S. ;

Guentner, Martina ;

Hozaeel, Wael ;

Reichart, Alexander .

LANCET, 2019, 393 (10184) :1948-1957

[3] Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Hofheinz, Ralf D. ;

Pauligk, Claudia ;

Kopp, Hans-Georg ;

Haag, Georg Martin ;

Luley, Kim Barbara ;

Meiler, Johannes ;

Homann, Nils ;

Lorenzen, Sylvie ;

Schmalenberg, Harald ;

Probst, Stephan ;

Koenigsmann, Michael ;

Egger, Matthias ;

Prasnikar, Nicole ;

Caca, Karel ;

Trojan, Joerg ;

Martens, Uwe M. ;

Block, Andreas ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Clemens, Michael ;

Illerhaus, Gerald ;

Zirlik, Katja ;

Behringer, Dirk M. ;

Schmiegel, Wolff ;

Pohl, Michael ;

Heike, Michael ;

Ronellenfitsch, Ulrich ;

Schuler, Martin ;

Bechstein, Wolf O. ;

Koenigsrainer, Alfred ;

Gaiser, Timo ;

Schirmacher, Peter ;

Hozaeel, Wael ;

Reichart, Alexander ;

Goetze, Thorsten O. ;

Sievert, Mark ;

Jaeger, Elke ;

Moenig, Stefan ;

Tannapfel, Andrea .

LANCET ONCOLOGY, 2016, 17 (12) :1697-1708

[4] Guidelines for the management of oesophageal and gastric cancer [J].

Allum, William H. ;

Blazeby, Jane M. ;

Griffin, S. Michael ;

Cunningham, David ;

Jankowski, Janusz A. ;

Wong, Rachel .

GUT, 2011, 60 (11) :1449-1472

[5] Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer [J].

Allum, William H. ;

Stenning, Sally P. ;

Bancewicz, John ;

Clark, Peter I. ;

Langley, Ruth E. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :5062-5067

[6] Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma [J].

Alnaji, Raed M. ;

Du, William ;

Gabriel, Emmanuel ;

Singla, Smit ;

Attwood, Kristopher ;

Nava, Hector ;

Malhotra, Usha ;

Hochwald, Steven N. ;

Kukar, Moshim .

JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (09) :1541-1546

[7] 18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making [J].

Anderegg, Maarten C. J. ;

de Groof, Elisabeth J. ;

Gisbertz, Suzanne S. ;

Bennink, Roel J. ;

Lagarde, Sjoerd M. ;

Klinkenbijl, Jean H. G. ;

Dijkgraaf, Marcel G. W. ;

Bergman, Jacques J. G. H. M. ;

Hulshof, Maarten C. C. M. ;

van Laarhoven, Hanneke W. M. ;

Henegouwen, Mark I. van Berge .

PLOS ONE, 2015, 10 (11)

[8] Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study [J].

Andre, Thierry ;

Tougeron, David ;

Piessen, Guillaume ;

de la Fouchardiere, Christelle ;

Louvet, Christophe ;

Adenis, Antoine ;

Jary, Marine ;

Tournigand, Christophe ;

Aparicio, Thomas ;

Desrame, Jerome ;

Lievre, Astrid ;

Garcia-Larnicol, Marie-Line ;

Pudlarz, Thomas ;

Cohen, Romain ;

Memmi, Salome ;

Vernerey, Dewi ;

Henriques, Julie ;

Lefevre, Jeremie H. ;

Svrcek, Magali .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) :255-+

[9] Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer [J].

Azad, Tej D. ;

Chaudhuri, Aadel A. ;

Fang, Penny ;

Qiao, Yawei ;

Esfahani, Mohammad S. ;

Chabon, Jacob J. ;

Hamilton, Emily G. ;

Yang, Yi D. ;

Lovejoy, Alex ;

Newman, Aaron M. ;

Kurtz, David M. ;

Jin, Michael ;

Schroers-Martin, Joseph ;

Stehr, Henning ;

Liu, Chih Long ;

Hui, Angela Bik-Yu ;

Patel, Viren ;

Maru, Dipen ;

Lin, Steven H. ;

Alizadeh, Ash A. ;

Diehn, Maximilian .

GASTROENTEROLOGY, 2020, 158 (03) :494-+

[10] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial [J].

Bahadoer, Renu R. ;

Dijkstra, Esmee A. ;

van Etten, Boudewijn ;

Marijnen, Corrie A. M. ;

Putter, Hein ;

Kranenbarg, Elma Meershoek-Klein ;

Roodvoets, Annet G. H. ;

Nagtegaal, Iris D. ;

Beets-Tan, Regina G. H. ;

Blomqvist, Lennart K. ;

Fokstuen, Tone ;

ten Tije, Albert J. ;

Capdevila, Jaume ;

Hendriks, Mathijs P. ;

Edhemovic, Ibrahim ;

Cervantes, Andres ;

Nilsson, Per J. ;

Glimelius, Bengt ;

van de Velde, Cornelis J. H. ;

Hospers, Geke A. P. .

LANCET ONCOLOGY, 2021, 22 (01) :29-42

← 1 2 3 4 5 6 7 8 9 10 →